Relationship Between Mrna Expression of Metastasis Suppressor Gene Nm23 and Clinicopathological Features and Prognosis of Non Small Cell Lung Carcinoma

WANG Hai-feng,CHEN Xiao-feng,DING Jia-an,GAO Wen,ZHOU Yi-ming,CHEN Qian-kun
DOI: https://doi.org/10.3781/j.issn.1000-7431.2006.10.009
2006-01-01
Tumor
Abstract:Objective: To investigate the relationship between the expression level of nm23 mRNA and the pathoclinical characteristics and the prognosis of patients with non-small cell lung carcinoma (NSCLC). Methods: We collected 53 specimens of NSCLC, 44 specimens of para-cancer normal lung tissues. The expression level of nm23 mRNA was measured by RT-PCR. The tumor stage was determined according to the results of surgery, pathological examination, and imaging diagnosis. Then analyses were carried out between the level of nm23 mRNA expression and the clinical variables. Results:The positive-rate of nm23 mRNA expression were 43. 4% (23/53) and 40. 9% (18/44) in specimens of lung cancer and para-cancer normal lung tissues, respectively (P0. 05). The expression level of nm23 mRNA was significantly decreased in low-differentiated, advanced, and mediastinal lymph node-metastatic NSCLC tissues (P0. 05). The median survival times were 43 months and 46 months for nm23-posi-tive and nm23-negative patients, respectively. But expression level of nm23 had no significant correlation with the prognosis of patients (P0. 05). Conclusion: The expression level of nm23 mRNA is related to the differentiation, metastasis, and pathological stage of lung cancer. There were no enough evidence demonstrating that nm23 expression correlated with the prognosis of patients.
What problem does this paper attempt to address?